• Kentucky hospital to pay $4.3M after employee stole 60K doses of narcotics

    Pikeville Medical Center in Lexington, Ky., will pay $4.39 million to resolve allegations that its failure to keep proper records resulted in the diversion of more than 60,000 opioid doses from its pharmacy, the U.S. Department of Justice said Dec. 7.
  • FDA authorizes tweaked boosters for young children

    The FDA expanded its emergency use authorizations for Moderna's and Pfizer's omicron-focused boosters Dec. 8 to include children as young as 6 months old. 
  • Mark Cuban Cost Plus partners with 2nd PBM; hints at insulin market entry

    Mark Cuban Cost Plus Drug Co. and pharmacy benefit manager EmsanaRx forged a partnership to launch EmsanaRx Plus Dec. 8. 
  • Former Cleveland Clinic pharmacy leader moves to Hims & Hers

    Scott Knoer, PharmD, the former chief pharmacy officer for Cleveland Clinic and CEO of the American Pharmacists Association, is now the chief pharmacy and innovation officer for telehealth and personal wellness company Hims & Hers. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • FDA hands Pfizer priority review for its RSV vaccine candidate

    As hospitals struggle to treat the surge of pediatric respiratory syncytial virus infections with a limited repertoire of treatments, the FDA placed Pfizer's RSV vaccine candidate on its fast-track list Dec. 7. 
  • FTC again probes Kroger's merger as the chain is set to lose $100M

    The Federal Trade Commission has sent a second request for information to Kroger regarding its $24.6 billion merger with Albertsons while the Cincinnati-based company is set to lose $100 million after dropping Express Scripts. 
  • 6 pharmacy organizations slam Cigna, Express Scripts for Tricare drop

    Pharmacist organizations scolded Cigna and Express Scripts for plans to drop 15,000 pharmacies from their 2023 Tricare networks, which could affect more than 400,000 people in the Defense Department's health plan.  
  • Modified vaccines less effective against new variants, 2 studies show

    Two studies have found the omicron booster to be lacking when it comes to its strength against new COVID-19 subvariants BQ.1.1, XBB and BA.2.75.2 — which, together, account for 38 percent of cases. 
  • Pfizer eyes the next COVID-19 drug

    As other COVID-19 drugs stumble in efficacy as the virus evolves, Pfizer and Cambridge, Mass.-based biotech startup Clear Creek Bio have partnered to develop a new treatment. 
  • The future hospital pharmacist

    It's time for a rebrand, hospital pharmacy directors told Becker's. 
  • Pfizer seeks FDA clearance for pediatric omicron booster

    On Dec. 5, Pfizer applied for the FDA's emergency use authorization on its updated COVID-19 booster for children between 6 months and 4 years old.
  • 20 states allow pharmacists to prescribe birth control

    Pharmacists can now prescribe birth control in 20 states, and 10 other state legislatures are working toward expanding access to the contraception at pharmacy counters, according to the American Society of Health-System Pharmacists. 
  • 'Nocebos' more likely in vaccine-hesitant patients, study finds

    Being hesitant toward COVID-19 vaccines could result in more side effects after a shot is administered — a phenomenon of negative opinions spurring negative health outcomes, which is nicknamed "nocebos" — according to a study published Dec. 5 in Nature. 
  • Tamiflu generic shortage sees slight improvement

    The national shortage of oseltamivir, the generic of common flu drug Tamiflu, has seen a slight reprieve despite flu hospitalizations hiking and Tamiflu demand spiking weeks earlier than normal. 
  • Drugmaker didn't expect weight-loss drugs to go viral as supply flounders

    Denmark-based Novo Nordisk wasn't prepared for Wegovy and Ozempic — which are approved for weight-loss and diabetes, respectively — to go viral, The Wall Street Journal reported Dec. 4. 
  • President of pharma lobby resigns

    The Association for Accessible Medicines has named David Gaugh as its interim CEO after the departure of former CEO and president Dan Leonard. 
  • CVS tests technology for remote pharmacists to review prescriptions

    CVS Health has equipped a majority of its 9,000 pharmacies with technology for its workers to review and enter prescription information without being in the store, The Wall Street Journal reported Dec. 4. 
  • Pharmacy owner connected to meningitis outbreak gets 1 year in prison

    A federal court sentenced the former co-owner and vice president of New England Compounding Center — which was ground zero for the 2012 fungal meningitis outbreak that killed 100 people — to one year in prison. 
  • U-M Health Hazards committee to launch USP hazardous drug handling standards

    The U-M Health Hazardous Drug Oversight Committee is reclassifying hazardous drugs and rolling out United States Pharmacopeia Hazardous Drug Handling standards on Feb. 28, according to a Dec. 1 article on the Michigan Medicine website.

Featured Whitepapers

Featured Webinars